Neural stem cell therapy for ALS: a phase 2 trial
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This trial tests whether injecting neural stem cells into the spine can slow down ALS. It is for people with rapidly progressing ALS who have good lung function and a caregiver to help with visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have a definite or probable ALS diagnosis (using standard criteria).
- Your ALS symptoms started less than 2 years ago.
- Your breathing is still strong (more than 70% of normal on a breathing test).
- Your ALS is progressing quickly (at least a 1-point drop per month on a function scale during a 12-week check period).
- You have a caregiver who can come with you to all study visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new stem cell treatment called NurOwn for people with early ALS (within 2 years of symptoms) who still have good breathing and daily function. The goal is to see if it can slow the disease.
This trial studies an experimental drug called LTX-002 for people with ALS. It aims to see if the drug is safe and can slow down the disease.
This trial is testing a new way to deliver nerve growth factor using tiny, protective nanocapsules injected into the body. The goal is to see if this treatment can slow the progression of ALS (Lou Gehrig's disease) and help maintain muscle strength and breathing function.
This trial tests a new drug called TP04HN106 for people with ALS. It aims to see if it is safe and if it might slow down the disease. You may qualify if your breathing is still fairly good and you have been on a stable dose of riluzole.
This trial tests a nasal drop made from tiny cell particles (extracellular vesicles) for ALS. The goal is to see if it's safe and if it can slow down the disease. It may be an option if your ALS is in the early to moderate stage.
This study tests whether bone-marrow stem cells can improve nerve function in people with nerve damage that usually doesn’t recover with current care. It also checks whether the treatment is safe and whether people can be followed over time with repeated nerve exams.
Hear when a new Amyotrophic Lateral Sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.